SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-06
👔
Arcutis Biotherapeutics, Inc.
@ARQT_InsiderForm 4 Filing: Matsuda Masaru Sells $32,123.664 of $ARQT
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Arcutis Biotherapeutics, Inc.
Ticker: $ARQT
Transaction Value
$32,123.664
Price/Share: $26.12
transaction date
2026-08-03
Shares: 1,230
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Matsuda Masaru, holds the title of See Remarks at Arcutis Biotherapeutics, Inc..
On 2026-08-03, the insider transacted 1,230 shares.The shares were transacted at a weighted average price of $26.12 per share, resulting in a total market-relevant value of $32,123.664.
Executive Summary Summary
Matsuda Masaru (See Remarks) sold $32K of $ARQT
Post-Transaction Position: 126,171 shares
SEC Accession No: 0001628280-26-053754 (CIK: 1798679)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.